A detailed history of Sherbrooke Park Advisers LLC transactions in Johnson & Johnson stock. As of the latest transaction made, Sherbrooke Park Advisers LLC holds 10,597 shares of JNJ stock, worth $1.65 Million. This represents 0.49% of its overall portfolio holdings.

Number of Shares
10,597
Holding current value
$1.65 Million
% of portfolio
0.49%

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2024

Feb 14, 2025

BUY
$143.34 - $165.86 $1.52 Million - $1.76 Million
10,597 New
10,597 $1.53 Billion
Q2 2024

Aug 14, 2024

SELL
$144.38 - $157.78 $1.44 Million - $1.57 Million
-9,949 Reduced 44.88%
12,219 $1.79 Billion
Q1 2024

May 15, 2024

BUY
$155.22 - $162.74 $1.74 Million - $1.82 Million
11,212 Added 102.34%
22,168 $3.51 Billion
Q4 2023

Feb 14, 2024

BUY
$145.6 - $158.88 $1.6 Million - $1.74 Million
10,956 New
10,956 $1.72 Billion
Q4 2022

Feb 14, 2023

BUY
$160.2 - $179.79 $432,539 - $485,433
2,700 New
2,700 $477 Million

Others Institutions Holding JNJ

About JOHNSON & JOHNSON


  • Ticker JNJ
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,614,479,872
  • Market Cap $408B
  • Description
  • Johnson & Johnson, together with its subsidiaries, researches and develops, manufactures, and sells various products in the healthcare field worldwide. The company's Consumer Health segment offers baby care products under the JOHNSON'S and AVEENO Baby brands; oral care products under the LISTERINE brand; skin health/beauty products under the...
More about JNJ
Track This Portfolio

Track Sherbrooke Park Advisers LLC Portfolio

Follow Sherbrooke Park Advisers LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Sherbrooke Park Advisers LLC, based on Form 13F filings with the SEC.

News

Stay updated on Sherbrooke Park Advisers LLC with notifications on news.